Type-I interferon secretion in the acute phase promotes Cryptococcus neoformans infection-induced Th17 cell polarization in vitro

Abstract

Cryptococcosis is a potentially fatal fungal disease commonly identified in patients with acquired immunodeficiency syndrome. Cryptococcus infection induces strong pro-inflammatory cytokine secretion, i.e. type-I interferon (IFN-I) via the Toll-like receptor signaling pathway. However, innate immune responses are insufficient in host defense against fungi infection and the clearance of Cryptococcus is dependent on the T helper (Th)17 cell-mediated mucosal immune response. In this study, IFN-I was identified as the early response cytokine to Cryptococcus neoformans infection via quantitative PCR (qPCR) and IFN-I was demonstrated to be crucial for interleukin (IL)-17A secretion in T cells, but not in innate immune cells. In addition, blockade of IFN-I reduced the protein expression levels of IL-22 and IL-23 in Th17 cells in vitro. These results suggest additional functions of IFN-I in immune regulation, which may be pivotal for the development of clinical immune therapy.

Introduction

Cryptococcosis, or cryptococcal disease, is a potentially fatal fungal disease caused by Cryptococcus neoformans or Cryptococcus gattii in patients with acquired immunodeficiency syndrome. Cryptococcal meningoencephalitis results in >600,000 fatalities every year (1). As a fungal infection, the limitation and clearance of cryptococcosis is mostly dependent on innate immune cells, such as dendritic cells (DC), natural killer cells (NK) and neutrophils. Briefly, Cryptococcus infection induces secretion of pro-inflammatory cytokines, including type-I interferon (IFN-I), tumor necrosis factor-α, interleukin (IL)-1β and IL-6, from innate immune cells (2). Studies have suggested that myeloid differentiation primary response gene 88 (MyD88)-mediated Toll-like receptor (TLR) signaling pathways, such as TLR2, TLR4 and TLR9, are involved in this secretory process (3,4). However, in a more recent study, TLR4 was observed to not be required for host defense against cryptococcal infection (5). In addition, Ley et al (6)suggested that TLR signals have a limited role in the clearance of Cryptococcus, as MyD88- and TLR-deficient mice were able to survive following cryptococcal infection (6).

By contrast, the roles of adaptive immune cells in the generation of protective anti-cryptococcal infection immune responses have been widely accepted. Studies have shown that increased IL-17A production, a pro-inflammatory cytokine which is predominantly secreted by CD4⁺ T cells, is associated with cryptococcal burden (5,7). Furthermore, IL-17A secreted by CD4⁺ T helper (Th)17 cells is involved in multiple roles as a ‘bridge’ that is associated with innate and adaptive immune responses. Its primary functions include inducing pro-inflammatory secretion in mucosal tissues (8) as a potent inducer. IL-17A can also enhance neutrophil chemotaxis by upregulating the production of granulocyte-colony stimulating factor and chemokine (C-X-C motif) ligand 1 (9). An increased Th17 cell population has also been found to inhibit the generation of Treg cells (10) and promote the clearance of fungal infections. Notably, IL-17A is also secreted by other cells, such as γδ T cells, CD8⁺ T cells, NK T cells, NK cells and neutrophils (11–13).

Differentiation of Th17 cells is dependent on IL-6 and transforming growth factor-β (TGF-β) signals; however, MyD88 was previously identified to enhance Th17 polarization by inducing IL-1β and IL-23 production (14). Activation of TLR signals in antigen-presenting cells (APCs) skewed Th subset development in the thymus and the peripheral tissues (15). Additionally, endotoxin exposure, which can specifically activate TLR4 signaling pathways in the Blomia tropicalis allergens infection model, shifted Th2 cell response towards the Th17 cell-mediated immune response (16). These results indicate that TLR signaling may be involved in Th17 cell-mediated host anti-cryptococcal infection, particularly in Th17 cell differentiation. In the present study, the effect of C. neoformans-induced release of IFN-I on immune regulation was determined. TLR signaling pathways were blocked and IFN-I secretion was examined with neutralizing antibodies.

Materials and methods

Cell culture and Pam3CSK4 treatment

Human peripheral blood mononuclear cells (PBMCs) were cultured in Dulbecco’s modified Eagle’s medium (Gibco-BRL, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal calf serum, 100 U/ml penicillin and 100 μg/ml streptomycin, then incubated at 37°C in 5% CO₂. Cultured cells were treated with 0.1 μg/ml tripalmitoyl-S-glyceryl-cystein (Pam3CSK4; 910.5 Da; EMC microcollections; Tübingen, Germany) in the medium to activate the TLR2 signaling pathway.

Cryptococcus strains and culture conditions

The encapsulated C. neoformans strain 11959 (ATCC 90112) was cultured in medium containing 1% yeast extract, 1% peptone and 2% glucose at 30°C for 2 days. The cell suspension was mixed with glycerine and stored at −80°C. C. neoformans was heat-killed at 65°C for 30 min and 10⁹ fungi/ml medium was added to the co-culture.

Quantitative polymerase chain reaction (qPCR)

Total RNA was harvested from cells, treated with DNase and reverse transcribed as previously described (17). Universal human (h)IFN-I primers were as follows: Forward, 5′-ATG GCT AGR CTC GTG CTT TCC T-3′ (R is a wobble of A or G) and reverse, 5′-AGG GCT CTC CAG AYT TCT GCT CTG-3′ (Y is a wobble of C or T); hIFN-γ forward, 5′-TCA AGT GGC ATA GAT GTG GAA-3′ and reverse, 5′-CAC TCG GAT GAG CTC ATT GA-3′; hIL-1β forward, 5′-AAA CCT CTT CGA GGC ACA AG-3′ and reverse, 5′-CTG TTT AGG GCC ATC AGC TT-3′; hIL-6 forward, 5′-GAC AAC TTT GGC ATT GTG G-3′ and reverse, 5′-ATG CAG GGA TGA TGT TCT G-3′; hIL-17A forward, 5′-CTG TGT CTC TGA TGC TGT TG-3′ and reverse, 5′-ATG TGG TGG TCC AGC TTTC-3′; and hGAPDH, forward 5′-ACC ACA GTC CAT GCC ATC AC-3′ and reverse, 5′-CAC CAC CCT GTT GCT GTA GCC-3′. Relative abundance of each cDNA was normalized to corresponding GAPDH levels and quantified using the ΔCT method.

Cytokine assays

T-cell derived cytokine levels, IL-17A, IL-22 and IL-23, were determined in the cultured supernatant after 7 days of incubation using commercially available ELISA kits (R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions. Lower detection limits were 40 and 78 pg/ml for IL-17 and IL-22/23, respectively.

Blockade of IFN-I signal with antibody in mice splenocytes

Splenocytes were isolated from the spleen of female C56Bl/6 mice and treated with isotype antibody or anti-IFN-IR1 antibody 0.1 mg/ml (Invitrogen, Carlsbad, CA, USA).

Statistical analysis

Results from at least three repeat experiments were pooled and analyzed using GraphPad Prism 5 software (GraphPad Software, Inc., San Diego, CA, USA). Data are expressed as the mean ± standard error. P<0.05 was considered to indicate a statistically significant difference.

Results

Cryptococcal infection induces early IFN-I expression prior to Th17 cell activation in vitro

C. neoformans infection was established in vivo with co-cultured human PBMCs and heat-killed C. neoformans in vitro. As previously reported, Cryptococcus infection induces pro-inflammatory cytokine secretion in innate cells and is mostly independent on peroxisome proliferator-activated receptor (PPAR), and other factors including TLR family, MyD88 and NF-κB were reported activated in the clearance of C. neoformans. In the present study, the production of TLR signaling molecules and the levels of IFN-I and IFN-γ were examined following C. neoformans infection, as well as various cytokines that are critical for Th17 cell differentiation, such as IL-1β, IL-6 and IL-17A, at various time points following qPCR. The results suggested there were no significant difference in IL-17A expression levels in the early phase (<4 h) following infection when compared mRNA expression in 1 h and 2 h with that in 0.5 h (P_{0.5 vs. 1}=0.1182 and P_{0.5 vs. 2}=0.2431). However, C. neoformans treatment induced strong expressions of pro-inflammatory cytokines IFN-I, IFN-γ and IL-1β, which were quite different from the media mock group.

Blockade of IFN-I signals decreases IL-17A expression levels in T cells

Previous studies on IFN-I have suggested that members of the IFN-I family induce transcription of numerous target genes involved in host anti-virus and -bacterial infection (13,14). However, fungal infection is commonly recognized via the TLR2, TLR4 and TLR6 signaling pathways and does not result from the secretion of IFN-I. In the present study, a peak expression of IFN-I was noted in the early phase (<0.5 h) of C. neoformans infection. This transient expression of IFN-I occurred prior to the release of additional cytokines and its function was clear such as inducing synthesis of NO and activation of macrophages. To examine whether heightened IFN-I secretion was necessary for Th17 cell development and IL-17A production, the IFN-I-receptor (R) was blocked with anti-IFN-I receptor neutralizing antibodies in the co-culture model and the TLR2 agonist, Pam3CSK4, was used to activate TLR signaling pathways as the control. Notably, no significant differences in IL-17A production were observed via ELISA (data not shown). Considering that neutrophils in human PBMCs are a major source of IL-17A (13), this treatment was repeated in mice splenocytes, which have a lower number of neutrophils than PBMCs, and found that blockade of IFN-I reduced IL-17A secretion levels after 7 days of co-culture. In addition, Pam3CSK4-treated mice splenocytes did not express the high levels of IFN-I (data not shown) and IL-17A observed in the control group (Fig. 2).

Figure 2.

IL-17A expression levels following 7 day co-culture of mice splenocytes with C. neoformans in the absence or presence of anti-IFN-I-R antibodies. IL, interleukin; IFN-I-R, type-I interferon receptor.

Blockade of IFN-I signals inhibits Th17 cell development in vitro

To understand IFN-I and its roles in Th17 cell development, the expression of IL-22 and IL-23 was determined in co-cultured mice splenocytes. IL-22 is the key factor in the mucosal immune response and clearance of pathogenic microbes (15). IL-23 promotes naive CD4⁺ T cell differentiation towards Th17 cells (18,19), and IL-22 and IL-23 are produced by Th17 cells. In the present model, blockade of IFN-I signals in C. neoformans co-cultured mice splenocytes with anti-IFN-I receptor neutralizing antibodies resulted in decreased expression levels of IL-22 and IL-23 compared with that of the control group after 7 days of culture (P=0.0453) (Fig. 3). These results suggest that the expression levels of IFN-I in the early phase of C. neoformans infection may have a guiding role in Th17 cell differentiation and host anti-fungal immune responses.

Figure 3.

IL-22 and IL-23 expression levels following 7 day co-culture of mice splenocytes with C. neoformans in the absence or presence of anti-IFN-I-R antibodiess. IL, interleukin; IFN-I-R, type-I interferon receptor.

Discussion

Cryptococcosis is a disease resulting from fungal infection. Although a number of cell subsets, such as neutrophils and DCs, are involved in the clearance of Cryptococcus spp., Th17 cells and innate cells are accepted as the major regulatory factors (16). The recognition of pathogenic microbes via PPAR family members is important to activate local inflammations in the early phase of infection. Recent studies (20–22) have shown that MyD88-mediated TLR signals are involved in the clearance of Cryptococcus via cytokine secretion; however, the mechanisms of these cytokines in immune regulation remain unclear.

In the present study, human PBMCs and heat-killed C. neoformans were co-cultured to mimic cryptococcal infection in human PBMCs to examine the cytokine profile at various time points. Results suggest that heat-killed C. neoformans increased the expression levels of IFN-I, IL-1β and IL-6 in the acute phase of infection and enhanced IL-17A production after 2 h (data not shown). Notably, the recognition of C. neoformans was mediated by TLR2, TLR4 and/or TLR6, which did not result in high levels of IFN-I secretion. To understand whether IFN-I is necessary in the host anti-fungal immune response, the IFN-I-R signal was blocked with anti-IFN-I-R neutralizing antibodies. This blockade of IFN-I was found to specifically reduce IL-17A expression in mice splenocytes, but had almost no effect on human PBMCs. Considering that there were numerous IL-17A-producing innate cells (such as neutrophils and γδ T cells) in human PBMCs, we speculated that IFN-I may be important for Th17 cell polarization, however, the mechanisms remain unclear. Further examination of IL-22 and IL-23 expression levels were also consistent with this hypothesis.

The common opinion regarding Th17 cell development both in vitro and in vivo suggests that the polarization of Th17 cells is regulated by IL-6 and TGF-β, which is secreted by adipocytes (23,24). However, the mechanisms may be more complex. A previous bioinformatic study of Th17 cell differentiation (25) suggested that a number of transcription factors, such as signal transducer and activator of transcription 3 (STAT3), interferon regulatory factor-4 (IRF4) and basic leucine zipper transcription factor, ATF-like, are activated much earlier than IL-17A gene transcription. In addition, a study of DC subsets identified that IRF4 transcription-factor-dependent CD103⁺ DCs specifically directed Th17 cell polarization (26). In the present study, we reported that IFN-I expression was detected in the early phase in C. neoformans infection but not IL-6 or IL-17 expression. In addition, the activation of IFN-I expression was required in the followed immune responses as blockade of IFN-I signal downregulated cytokines IL-17, IL-22 and IL-23 secretions in vitro. These finding suggest the critical roles of IFN-I in the clearance of fungi infection and provided direction for the future treatment of cryptococcosis.

Figure 1.

Relative expression levels of cytokines following co-culture of human peripheral blood mononuclear cells with C. neoformans. Data are expressed as fold change of C. neoformans-treated group versus media mock group. IL, interleukin.